Company Overview
Snapshot
Founded in January 2024 by Dr. Tal Patalon and Dr. Oren Elisha, Medana operates with 11–50 employees. The company has raised $2.28M across one funding round from one investor. In April 2025, Medana secured seed funding from Maccabi Foundation.
Business overview
Medana is an Israeli startup in the Health Tech & Life Sciences sector, focused on bridging the gap between AI and real-world medical implementations. The company develops a foundational layer for AI-driven medicine, transforming static, fragmented data into a dynamic, proactive, and AI-ready infrastructure. Medana's core technology leverages Artificial Intelligence to serve the healthcare industry, specifically targeting providers within the Digital Healthcare market.
Strategic signal
In April 2025, Medana announced its entry into the Spanish market with its AI platform, aiming to transform healthcare across Europe. This expansion signals the company's strategic intent to scale its AI-driven medical solutions internationally, indicating a strong growth trajectory and validation of its technology's applicability beyond its initial market.
Log in to access full profile ›Company Intelligence Q&A
- When was Medana founded?
- Medana was founded in January 2024 by Dr. Tal Patalon and Dr. Oren Elisha.
- What is Medana's primary focus?
- Medana focuses on creating a foundational layer for AI-driven medicine, transforming static and fragmented data into a dynamic, proactive, and AI-ready infrastructure to bridge the gap between AI and real-world medical implementations.
- Which market did Medana enter in April 2025?
- In April 2025, Medana entered the Spanish market with its AI platform to transform healthcare across Europe.
- How much capital has Medana raised to date?
- Medana has raised a total of $2.28M across one funding round.
- Who participated in Medana's seed funding round?
- In April 2025, Medana secured $2.28M in seed funding from Maccabi Foundation.